The bone biopsy
market is projected to be worth USD 964.55 million by 2030 at a CAGR of 5.25%
during the forecast period 2022-2030.
The increased
cancer detection rate is a major factor adding to the expansion of the market
of bone biopsy. Reports that examine the healthcare industry have been offered
by Market Research Future, which produces reports on industry verticals that
evaluate market development and opportunities. The market is projected to gain
a CAGR of 5.25 % in the forecast period.
The growing demand
for new diagnostic procedures is a notable factor that is transforming the bone
biopsy market. The increased spending on the healthcare sector is leading to
the development of advanced procedures for bone biopsy. The increased level of
oncology-related knowledge acquired is expected to benefit the market for bone
biopsy in the coming years.
Segmental Analysis
The segmentation
evaluation of the bone
biopsy market is carried out on the basis of type, region,
application, and end-user. Based on the component, the bone biopsy market is
segmented into open biopsy and needle biopsy. On the application basis, the
market is segmented into bone infection, osteoporosis, bone cancer, chronic
kidney disease, and others. By end-user, the bone biopsy market is segmented
into surgical centers, hospital & clinics, diagnostic centers, and others.
By region, the bone biopsy market is segmented into the Americas, APAC, Europe,
the Middle East, and Africa.
Detailed Regional Analysis
The regional study
of the bone biopsy market states that the Americas region holds the primary
position in the bone biopsy market due to the intensifying prevalence of cancer
in the U.S. and growing demand for novel cancer diagnostic and treatment services.
In the Americas, the North American region is the principal market due to the
incidence of key companies in the healthcare diagnostics industry. The changing
lifestyle patterns, emphasis on exercise and fitness, and general development
of the medical device industry are accelerating the growth of the market. The
European region is the subsequent principal market for bone biopsy. In the
European region, there is a growing demand for progressive bone biopsy devices
and massive research and development activities by clinical research and
academic institutes for cancer treatment and diagnosis. Germany is the
principal market shadowed by France. The market in Germany is motivated by the
growing demand for specialty care services. The APAC regional market is anticipated
to expand at the fastest pace and is guided by the high occurrence of chronic
diseases such as obesity, kidney disease, diabetes, and others. Japan, India
China are major contributors to the growth of the market. This growth is
attributed to escalating demand for technologically advanced medical devices in
diagnostic centers and the availability of highly qualified medical
professional devoted to research in oncology. The MEA region also shows a
stable rise in the market due to low technology diffusion and growing awareness
about cancer treatment. In the MEA region, the United Arab Emirates gains the
largest market share for bone biopsy due to the accessibility to better
healthcare infrastructure and extensive scope for research.
Competitive Analysis
The development of
the alternative courses of action in terms of both their expenses and
consequences are steering the growth of the market. The state of the assets is
also thoroughly examined to determine whether an investment is required to
maintain the marketing system in its existing, unimproved state. The need to
establish cost-benefit analysis is leading to enhanced product development in
the market. The market players are concentrating on strategies that lead to the
highest degree of development in the market. The market competitors are also
carefully scrutinizing whether intervention is required to ensure efficient use
of society’s resources. The trade-offs between the resources needed to manage
the challenges in the market are being carried out increasingly to improve the
market’s scope for development. They are also making the most effective use of
resources which is dependent on an effective appraisal and planning process.
The significant
contenders in the bone biopsy market are Becton, Dickinson, and Company (U.S.),
Devicor Medical Products Inc. (U.S.), B. Braun Melsungen AG, Hologic, Inc.
(U.S.), C R Bard (U.S.), Cook Medical (U.S.), Argon Medical Inc. (U.S.) and
others.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
0 Comments